Bristol-Myers Squibb Co. et al v. Merck & Co., Inc. et al. 1:15-cv-00572; Filed: 07/
07/2015; Case Updated Daily; Latest Docket Entry: 11/15/2016; PACER.
Aug 11, 2016 ... Parties, docket activity and news coverage of federal case Gilead Sciences, Inc. v
. Merck & Co, Inc. et al, case number 5:13-cv-04057, from ...
Dec 1, 2014 ... PHOX, LaRONDA V. GEORGE E. FERN CO., ET AL. The motions to direct the
Clerk to file petitions for writs of certiorari out of time are denied.
Nov 3, 2014 ... COLEY PATRICIA ET AL VS MERCK & CO INC. 1/30/2009. 000367-09 .....
BARBER NORMA J V MERCK SHARP DOHME. 12/29/2010.
Nov 12, 2015 ... Barber et al. presented a case of a haemodialysis patient with septic ..... S. J. v. H.
has received grant support from Novartis, Pfizer, Merck and Gilead. ... here by
R. K. are her own and not necessarily those of Merck & Co., Inc.
REESE, MICHAEL , 541 U.S. 27 (2004), 03/02/04; BARBER, MICHAEL G., ET AL.
v. ... PRO FOOTBALL, INC., dba WASHINGTON REDSKINS, et al. , 518 U.S. 231
(1996), .... FEC, ET AL. , 540 U.S. 93 (2003), 12/10/03; MERCK & CO., INC., ET
AL. v. ... SCHLITZ BREWING COMPANY and Stroh Brewery Company et al. , 513
Sep 3, 2009 ... COMMUNICATIONS, INC.; from Bexar County; 4th district ..... 09-0037 AIG
ANNUITY INSURANCE COMPANY, ET AL. v. SEARS, ROEBUCK.
Nov 12, 2015 ... therapy. Barber et al.11 presented a case of a haemodialysis patient with ... y s et
al .56 infection clearan ce, with nega tiv e cultures repo rted, as a v ..... R. K. is
employed by Merck & Co, Inc., and owns Merck & Co, Inc. stock.
Apr 19, 2016 ... Barber DL, Wherry EJ, Masopust D, et al. Restoring function ... Pembrolizumab vs
ipilimumab in advanced melanoma. N Engl J Med. .... <sup>19</sup>Department of Clinical
Oncology, Merck & Co, Inc, Kenilworth, New Jersey. <sup>20</sup>BARDS ...
MELLON FINANCIAL CORPORATION, et al., Defendants. Civil Case ...
COUNSEL: [*1] For ROBERT M. HOWLEY, Plaintiff: KEVIN E. BARBER, LEAD
ATTORNEY, MATTHEW. JUSTIN ... For AFFILIATED COMPUTER SERVICES,
INC., Defendant: CYNTHIA V. FITZGERALD, LEAD .... Merck & Co., 384 F.3d 58,
65-66 (3d Cir.